← FDA Drug Approvals (Drugs@FDA)
NUZOLVENCE
NDA · New Drug Application · Sponsor: ENTASIS THERAP · Approved 2025-12-12
Drug application
- FDA Application #
NDA219491- Application type
- New Drug Application
- Brand name
- NUZOLVENCE
- Generic name
- ZOLIFLODACIN
- Active ingredients
- ZOLIFLODACIN
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ENTASIS THERAP
- Manufacturer
- La Jolla Pharmaceutical Company
- First approval
- 2025-12-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown